RAB24

Across TCGA pan-cancer cohorts, RAB24 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated RAB24 data layer compared with 26 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RAB24 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RAB24 expression acts as an unfavorable survival marker, although some lineages such as UCEC and CCRCC show a favorable association.

UCEC, PDAC, and COAD are the cancer types where RAB24 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	1.000	0.620	.011	36	view →
PDAC	DFS	Tertile	II,III,IV	0.530	0.869	.003	36	view →
COAD	DFS	Median	III,IV	0.838	1.000	.045	18	view →
LUAD	OS	Median	III,IV	0.747	1.000	.002	15	view →
CCRCC	DFS	Median	II,III,IV	0.887	0.283	.012	14	view →
HNSC	OS	Tertile	All	0.920	0.823	.017	10	view →
GBM	DFS	Median	All	0.452	0.291	.024	4	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RAB24–UCEC (OS)

Open the UCEC breakdown →